Chemotherapy in Treating Patients With Early-Stage Bladder Cancer

NCT00003129 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

75

Enrollment

NETWORK

Sponsor class

Conditions

Bladder Cancer

Interventions

DRUG: valrubicin

Sponsor

Eastern Cooperative Oncology Group

Collaborators

[object Object]